Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01024946 |
|---|---|
| Brief Title: | Everolimus (RAD001) for the Treatment of Malignant Pleural Mesothelioma With Merlin/NF2 Loss as a Biomarker to Predict Sensitivity |
| First Submitted : | December 2, 2009 |
| First Submitted that Met QC Criteria : | December 2, 2009 |
| First Posted : | December 3, 2009 (Estimate) |
| Results First Submitted : | April 7, 2015 |
| Results First Submitted that Met QC Criteria : | April 7, 2015 |
| Results First Posted : | April 20, 2015 (Estimate) |
| Last Update Submitted that Met QC Criteria : | April 21, 2015 |
| Last Update Posted : | May 12, 2015 (Estimate) |